We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Eptinezumab

Australian Public Assessment Report

AusPAR

AusPAR: Eptinezumab [PDF, 767.02 KB]

AusPAR: Eptinezumab [Word, 644.78 KB]

Attachment: Product Information for Eptinezumab [PDF, 383.85 KB]

Attachment: Product Information for Eptinezumab [Word, 250.36 KB]

Device/Product Name

Vyepti

Active ingredients

Eptinezumab

AusPAR Date

25 February 2022

Published

3 March 2022

Submission Number

PM-2020-01823-1-1

Submission Type

New biological entity

Decision

Approved